Emerging data has suggested that canagliflozin provides more benefits to patients with type 2 diabetes vs sitagliptin. In a recent study, researchers compared the effects of both treatments on glycemic...
Previous studies have shown that empagliflozin can significantly lower the risk of cardiovascular death vs placebo among individuals with type 2 diabetes and cardiovascular disease. In a recent study,...
In a recent study, researchers assessed the safety and efficacy of dapagliflozin as an add-on to insulin in patients with poorly controlled type 1 diabetes.
In a recent study, researchers tested pioglitazone and sulfonylureas as add-on treatment options for preventing cardiovascular events among patients with type 2 diabetes.
Using data from the DURATION-7 trial, researchers assessed the effects of adding once-weekly exenatide to titrated insulin glargine with or without metformin on HbA1c and weight loss among patients with...
It is well known that unhealthy lifestyle factors can lead to health problems over time, including type 2 diabetes. In a recent study, researchers assessed the impact of several lifestyle factors on the...
Previous research has suggested an association between red meat consumption and type 2 diabetes. A recent study sought to explore this relationship further, evaluating the effects of red meat, poultry,...
Type 2 diabetes is known to increase the risk of non-vertebral fractures in older men. However, less is known about the effect of diabetes on vertebral fractures in this patient population. A new study...
